Skip to main content
 

Epigenetics Interest Group

Epigenetics represents a new frontier in cancer research. Information in the genome exists in at least two forms, genetic and epigenetic. The genetic information provides the blue print for the manufacture of all the proteins necessary to create a living organism, whereas the epigenetic information provides additional instructions on how, where, and when the genetic information will be used. The focus of the Epigenetics Interest Group is on applications of epigenetic approaches in disease detection, risk assessment and treatment. The group meets on last Thursday of every month from 3-4 pm. Please contact Dr. Mukesh Verma at 240-276-6889 for more information.

Colleagues interested in epigenetics also may benefit from a spring course offered by the NIH FAES, "Biological Importance of Modifications in DNA and Chromatin." The learning objects are to: understand basic concepts behind epigenetics; understand why epigenetics is important to understanding human diseases; and explain how epigenetic mechanisms work. For more information and to register, see https://my.faes.org/Common/CourseSchedule.aspx and search for course BIOC532. The term period is January 22 to June 1, 2018.

___

Interesting Future Epigenetics meetings (see http://www.epigenie.com for more)

Chromatin Regulation: Insights from new methods and the genomics of human disease
by Gerald R. Crabtree
Monday, April 30, 2018
3:00 to 4:00 p.m., Building 10 (Clinical Center), Lipsett Amphitheater

Gerald R. Crabtree, M.D. is an Investigator with Howard Hughes Medical Institute. Dr. Crabtree is also a professor of pathology and of developmental biology at Stanford University School of Medicine. Dr. Crabtree's laboratory is studying the roles of chromatin in development and disease. His laboratory is making use of genetics and genomics in both humans and mice to understand the mechanisms used in chromatin regulation and how they go wrong in human disease. His laboratory members are also designing and synthesizing small molecules that rapidly and reversibly activate or inhibit chromatin regulatory mechanisms, thereby allowing precise kinetic analysis of their mechanisms and functions.

Chair

Advisor


The page was last updated on Friday, April 27, 2018 - 10:43am